drugset / Trial / NCT02256930

Skin Safety Study to Evaluate the Sensitizing Potential in Healthy Volunteers

NCT02256930

Phase 1 Completed 240 enrolled Maruho North America Inc.
RandomizedSingle-groupDouble-blind

Summary

This is a single center, randomized, controlled, within subject comparison, multiple dose study to determine the sensitization potential of M518101 on normal skin under occlusive patch condition.

Timeline

Start
2014-09
Primary completion
2014-11
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Subject pefcalcitol Small molecule Topical

Indications

No indication recorded.